Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

Vitamin D3-coated nanoparticles effectively deliver caffeine for alopecia treatment with minimal side effects.

Trichoscopy is useful for early detection and monitoring of female pattern hair loss.

Nyctanthes arbor-tristis has potential health benefits and needs more research for safe medicinal use.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Hair root dermoscopy is a simple, noninvasive tool to diagnose telogen effluvium.

Combining robotic and specialized tools improves hair transplant results.

Herbal hair serum promotes natural hair growth and maintains healthy hair.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

The study aims to create a model to improve personalized and preventive health care.

Growth factor concentrate therapy helps manage hair loss.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Scientists created a non-toxic, sugar-based hair product that can style hair without damage.

Deep learning can accurately detect Alopecia Areata with up to 98.3% accuracy.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.